论文部分内容阅读
在对照组治疗基础上，改安灭菌１．２ｇ静脉注射每日２次为经纤支镜行病变段支气管灌洗后气管内滴注安灭菌１．２ｇ隔日１次，治疗急性肺脓肿５０例。结果治疗组２周治愈率５２％，显效４０％，３周治愈率９２％，另８％最后确诊为癌性空洞。对照组２周治疗后体温降至正常者３６％，但咳嗽、咳痰症状及胸片无明显改善，４周治愈率１２％，显效率７４％，６周治愈率３０％，显效５６％，另１４％无效转院或转胸外科治疗。治疗组起效时间、平均治疗时间明显短于对照组（Ｐ＜０．０１），且无明显副作用。纤支镜检不但对急性肺脓肿病原学诊断有积极意义，经纤支镜对急性肺脓肿的介入治疗也是一种见效快、疗程短、安全有效的方法，值得临床推广应用。
In the control group based on the treatment, the safety and security 1.2g intravenous injection twice a day for bronchoscopy bronchial lesion bronchial lavage after endotracheal instillation 1.2g every other day for treatment of acute lung abscess 50 cases. Results The two-week cure rate of the treatment group was 52%, markedly effective 40%, three-week cure rate 92%, the other 8% of the final diagnosis of cancerous cavity. The control group 2 weeks after treatment, the body temperature dropped to 36% of normal, but cough, sputum symptoms and no significant improvement in chest X-ray, 4 weeks cure rate of 12%, markedly effective rate of 74%, 6 weeks cure rate of 30%, markedly effective 56% Another 14% invalid transfer or thoracic surgery. The onset time and average treatment time of the treatment group was significantly shorter than that of the control group (P <0.01), and no obvious side effects. Bronchoscopy is not only positive for the diagnosis of acute pulmonary abscess etiology, bronchoscopy for acute lung abscess intervention is also a quick, short course, safe and effective method, it is worthy of clinical application.